comparemela.com

Latest Breaking News On - Ori ben yehuda - Page 1 : comparemela.com

FDA Advisory Committee Votes in Favor of Abbott's First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

Panel of independent experts reviewed data from the TRILUMINATE pivotal trial demonstrating safety, effectiveness and quality-of-life benefits of the TriClip system

United statesRebecca hahnDavid adamsWilliam abrahamAbbott triclipAndreas briekeFederico aschMount sinai health systemIcahn school of medicine at mount sinaiDrug administrationCirculatory system devices panelMedical devices advisory committeeIcahn schoolMount sinaiValve repairTricuspid valve imaging

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US

San franciscoUnited statesMichael daleAndreas briekeDavid adamsFederico aschRebecca hahnWilliam abrahamMount sinai health systemYork heart associationIcahn school of medicine at mount sinaiCardiovascular research foundationTranscatheter cardiovascular therapeuticsKansas city cardiomyopathy questionnaireIcahn schoolMount sinai

Statins Post-PCI: Moderate-Intensity and Add Ezetimibe?

The reward for avoiding high-intensity-statin monotherapy could be better safety and clinical outcomes, suggests a registry study that supports randomized evidence.

South koreaSoult ukpyolsiNew yorkUnited statesSan diegoLa jollaDeepakl bhattMount sinai health systemYonsei university college of medicineUniversity of californiaJournal of the american college cardiologySulpizio cardiovascular centerAmerican collegeSeverance hospitalYonsei university collegeNew york city

New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease

Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves

France generalAndreas briekePhilipp lurzWilliam abrahamAbbott triclipRebecca hahnMichael daleFederico aschEuropean association of the percutaneous cardiovascular interventionsYork heart associationHeart center leipzig at universityEuropean associationPercutaneous cardiovascular interventionsDay outcomes fromNew york heart associationFunctional class

World-Renowned Cardiologists and Cardiac Surgeons to Feature Innovative Heart Failure Therapies at Technology and Heart Failure Therapeutics, March 20-22, 2023

/PRNewswire/ WHAT: Innovative therapeutic approaches for left ventricular restoration for patients with Heart Failure with Reduced Ejection Fraction (HFrEF)..

United statesOri ben yehuda bioventrix incInvestigational useMichael pfeiffer penn state hershey medical centerBioventrix incHeart failureReduced ejection fractionLeft ventricularLess invasive ventricular enhancementBioventrix reviventTranscatheter ventricular enhancementBoston seaport districtCardiac surgeonsGuideline directed medical therapyLeft ventricleInterventional heart failure

vimarsana © 2020. All Rights Reserved.